Search filters

List of works by Max M van Noesel

Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients

scientific article published on 3 January 2017

Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)

scientific article published on 18 June 2020

Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers

scientific article

Gastrointestinal Stromal Tumours (GIST) in Young Adult (18-40 Years) Patients: A Report from the Dutch GIST Registry

scientific article published on 20 March 2020

MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis

scientific article

Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma

scientific article

Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients

scientific article published on 12 January 2016

Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease

scientific article published on 17 November 2019

Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study

scientific article published on 30 December 2019

Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study

scientific article published on 26 June 2019

Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 study

scientific article published on 28 March 2019

PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma

scientific article published on 6 October 2008

Peripheral stem cell apheresis is feasible post Iodine-metaiodobenzylguanidine- therapy in high-risk neuroblastoma, but results in delayed platelet reconstitution

scientific article published on 12 October 2018

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

scientific article

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors

scientific article published on 2 November 2015

The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients

scientific article

Treatment and outcome of neuroblastoma with intraspinal extension: A systematic review

scientific article published on 2 February 2017

Treatment of malignant peripheral nerve sheath tumors in pediatric NF1 disease

scientific article published on 03 June 2020

Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan

scientific article published on 15 May 2015

Use of quality indicators in neuroblastoma treatment: A feasibility assessment

scientific article published on 31 July 2020

Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma

scholarly article by Esther M. van Wezel et al published January 2015 in The Journal of Molecular Diagnostics

Paulina is supported by:

About Paulina

Help